-
Determination of total, unbound, and intracellular concentrations of the antiretroviral drugs Efavirenz, Lopinavir, and Ritonavir
-
Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis
-
Population pharmacokinetic modelling for dose optimization of esomeprazole to treat early-onset preeclampsia
-
And therapeutic outcomes lopinavir-ritonavir and a rifampicin containing anti-tuberculosis pharmacokinetics in children with tuberculosis/hiv co-infection treated with regimen
-
Pharmacogenomics and pharmacokinetics of antiretroviral drugs and their associations with metabolic complications in HIV-infected Black South Africans
-
Pharmacokinetics, pharmacogenetics and optimisation of treatment with non-nucleoside reverse transcriptase inhibitors in HIV-infected African children
-
Characterizing population pharmacokinetic/pharmacodynamic relationships in pulmonary tuberculosis infected adults using nonlinear mixed effects modelling
-
Pharmacogenomics and pharmacokinetics of dolutegravir and tenofovir in Southern Africans living with HIV
-
Population pharmacokinetics and pharmacokinetic-pharmacodyamic modeling of antitubercular drugs
-
Population pharmacokinetic modelling to address the gaps in knowledge of commonly used HIV and TB drugs in children
-
Determinants and consequences of the pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in a cohort of tuberculosis patients
-
Population pharmacokinetic and pharmacodynamic modelling to improve tuberculosis treatment
-
A pharmacokinetic and antimalarial efficacy evaluation of pyridodibemequines and their metabolites
-
A rising-dose tolerance study in health human subjects, examining increasing doses of chlorproguanil with a constant dose of dapsone
-
The antiplasmodial, toxicity and pharmacokinetic properties of synthetic derivatives of the natural product Curcumin
-
Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated Falciparum malaria
-
Pharmacokinetic-Pharmacogenetic-and-Pharmacodynamic Adherence Relationships in Cohort South African HIV Infected Children on Lopinavir-and Nevirapine-Based Regimens
-
Clinical, pharmacokinetic, and genetic determinants of change in serum creatinine among Southern Africans on dolutegravir based antiretroviral therapy
-
Effect of obesity on dolutegravir exposure in Black Southern African adults living with HIV
-
The Plasma, Whole Blood and Intracellular Concentrations of Antiretroviral Agents in South African Children Receiving Combination Antiretroviral Therapy with and without Concomitant Antitubercular Treatment
-
Development and validation of liquid chromatography mass spectrometry (L/C/MS/MS) assay for the determination of plasma 4betahydroxycholestrol and cholesterol in HIV infected children in Africa
-
The pharmacologenetics of lopinavir in a cohort of black African HIV/AIDS patients
-
The maladaptive effects of HIV protease inhibitors (Lopinavir/Ritonavir) on the rat heart
-
The Use of Combinations of Chemosensitisers to Reverse Chloroquine Resistance in Mice infected with Malaria
